top of page

Thu, 18 Nov

|

Webinar

NICE’s interim decision for the treatment elosulfase alfa (Vimizim)

For all patients, carers and family members living with MPS IV Morquio to discuss NICE's interim decision.

Registration is closed
See other events
NICE’s interim decision for the treatment elosulfase alfa (Vimizim)
NICE’s interim decision for the treatment elosulfase alfa (Vimizim)

Time & Location

18 Nov 2021, 19:00 GMT

Webinar

About the Event

A webinar for all patients, carers and family members living with MPS IV Morquio to discuss NICE's re-evaluation process, their interim decision for the treatment elosulfase alfa (Vimizim), the work that we and the clinical teams are doing and what our patient community can do now to help.

Share This Event

bottom of page